Make plans to join us for a special presentation by
Dr. Joel Bornstein, PhD
Professor of Research
University of Melbourne, Australia
"The role of the enteric nervous system in bacterially induced diarrhea"
Department of Internal Medicine, Division of Infectious Disases
Basic Science Auditorium, Room 2.212
May 24, 2013
11:00a - 12:00p
Using research to keep Texans informed about cancer care – that is at the heart of the CERCIT project (Comparative Effectiveness Research on Cancer in Texas). Investigators are addressing important questions about cancer screening, the quality of cancer treatment, the quality of follow-up care and the quality of ongoing supportive care for cancer patients and survivors in Texas. Their work is funded through the Cancer Prevention and Research Institute of Texas (CPRIT).
The CERCIT research consortium is a multidisciplinary group of investigators from the University of Texas Medical Branch, University of Texas M. D. Anderson Cancer Center, the Texas Department of State Health Services Texas Cancer Registry, the University of Texas School of Public Health, Rice University, and the Baylor College of Medicine. A description of this project and selected articles from its four research areas are featured in the Spring 2013 issue of the Texas Public Health Journal, a quarterly publication of the Texas Public Health Association (pages 22-55).
The special section includes an overview of the project’s data, training and knowledge cores and four peer reviewed articles that discuss the use of BRCA testing in older women with breast and/or ovarian cancer in Texas, prostate cancer treatment patterns in Texas, the use of breast and prostate cancer screening in older adults in Texas, and the human and economic burden of cervical cancer in Texas.
The CERCIT project is led by principal investigator Dr. James S. Goodwin from the University of Texas Medical Branch (UTMB) and co-directed by Dr. Linda S. Elting from the University of Texas MD Anderson Cancer Center (MDA). Other project and core lead investigators include Drs. Sharon H. Giordano (MDA), Taylor S. Riall (UTMB), Catherine D. Cooksley (UTMB), Jean Freeman (UTMB), Karl Eschbach (UTMB), Anthony DiNuzzo (UTMB),Vivian Ho (Rice University) and Melanie Williams (Texas Cancer Registry). A complete list of CERCIT investigators may be found on the “About Us” page of our website at www.txcercit.org.
Animal Research Topics and IACUC Protocol Essentials
General: 3 day course, 3 hours each day
When: Tuesday, May 14th through Thursday, May 16th 2013
Where: RSH 1.130 Classroom
Who: This class is open to the campus; animal researchers and anyone involved with animal support at any level will benefit. Everyone is welcome.
What: This course is designed to prepare researchers to plan, prepare and conduct humane and compliant studies with animals according to federal and institutional laws, policies and guidelines. Guest speakers will include institutional leaders involved in the animal care and use program or areas which affect the animal program. After completing the course, students should:
- Appreciate the regulations and guidelines applicable to animal research developed by United States Department of Agriculture (USDA), the Public Health Service (PHS), and the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC)
- Identify functions and processes of UTMB’s Institutional Animal Care and Use Committee (IACUC), including IACUC protocol submission procedure and the committee’s review process
- Be familiar with proper IACUC protocol writing techniques and have knowledge of how to correctly respond to the various components of the protocol application
- Know the Animal Resource Center policies and procedures
- Understand animal research publishing guidelines and society views
- Recognize how the Post Approval Monitoring (PAM) program is a resource for animal research
Faculty members from the University of Texas’ six health institutions will have the chance to present their research to top executives from the nation’s major pharmaceutical companies at Texas FreshAIR’s inaugural roundtable conference Sept. 25-26, 2013 in Austin.
Texas FreshAIR (Academia Industry Roundtable) is a UT System initiative developed to promote partnerships and dialog between pharmaceutical companies and UT health institutions.
Senior executives from pharmaceutical companies such as Abbvie, Astellas, Astra-Zeneca, Biogen, GlaxoSmithKline, Johnson &Johnson, Merck, Sanofi-Aventis and Pfizer will attend the two-day FreshAIR event. A full list of the pharmaceutical representatives attending is posted on the FreshAIR website at www.utsystem.edu/offices/health-affairs/inaugural-texas-freshair-roundtable.
Faculty members at all six UT health institutions are encouraged to seize this unique opportunity to have their research reviewed by not one but several pharmaceutical companies.
Any faculty member who is interested in collaborating with the pharmaceutical industry is invited to submit a short, one-page summary of non-confidential research via the FreshAIR website at http://www.utsystem.edu/offices/health-affairs/texas-freshair-request-research-one-pagers. Faculty members whose research is selected for presentation at Texas FreshAIR will be notified.
Let’s astound the industry with the depth and breadth of science at the UT health institutions.
Submit research one-pagers by May 10!
Submit research one-pagers by May 10!
The Institute for Translational Sciences is accepting proposals to develop a new Multidisciplinary Translational Team, conduct translational pilot studies, and utilize novel methodologies.
Application materials are now available on the ITS website at: http://www.its.utmb.edu/resources/collaborative_studies.html
Applications Due: May 1, 2013
Anticipated Start Date: September 1, 2013
Contact: Email: Liz Ruiz
For: Institute for Translational Sciences
This course is part of the new Texas Regional CTSA Collaborative Innovation & Entrepreneurship Training Program, and was developed with the UTAustin McCombs School of Business to provide a detailed understanding of the steps required to commercialize technologies and develop a successful business. Learn more about this course by clicking on the image below.
On October 1st, 2013, the Transgenic Mouse Core Facility (TMCF) was placed under the administrative management of the Animal Resources Center (ARC) in partnership with the Institute for Translational Sciences (ITS).
The Transgenic Mouse Core Facility (TMCF) is committed to provide customized, flexible, and comprehensive services to UTMB investigators utilizing genetically engineered mouse models. The services we most commonly provide are generation of transgenic mice, gene targeting, cryopreservation of mouse embryos and sperm, rederivation, breeding, and genotyping. We also offer consultation and assist in grant/animal protocol writing. We are located on the ground floor of MRB, inside the ARC.
Director: Maki Wakamiya, PhD
Transgenic Mouse Core Facility
Institute for Translational Sciences
Animal Resource Center
University of Texas Medical Branch
301 University Blvd.
Galveston, TX 77555-0621
For more information please visit us at:
Learn how to log into ITS Direct Connect and submit a ticket for help with your translational research.
Using ITS Direct Connect is quick and easy! Get your answers directly from our offices at the Institute for Translational Sciences. View the video to find out how.
Management of Technology is the first in a series of online courses designed to introduce participants to a broad range of topics related to management of technology and technological innovation in biomedical fields. The course will include discussion of technology development in industry, academia and government, the process of innovation, the drivers of innovation in a global environment, organizing and leading innovation, and incorporating technology change into company structure and strategy. This course is offered jointly through the UTMB Institute for Translational Sciences (ITS) new Collaborative Innovation & Entrepreneurship Training Program.
The 8-week course begins February 25, 2013. The program is open to all interested UTMB and UT Houston Health Science Center faculty, researchers, postdocs and graduate students. UTMB graduate students and postdocs should register for HPTM 6290 to receive transcript credit for the course. A pre-requisite in "Foundations of Management" module must be successfully completed prior to the start of the course. This self-study reading will be supplied shortly after registration.
To find out more about the Institute for Translational Sciences, visit us at:
Register Now: “Epidemiological & Statistical Methods in Clinical Investigation” Course
“Epidemiological & Statistical Methods in Clinical Investigation”, is a series of 13 weekly sessions as a module in the Institute for Translational Sciences Education Program titled, “Clinical Research: Tools and Techniques”. This module will begin Monday, February 25, 2013, 5:15 p.m., Research Building 6 (formerly Children’s Hospital), Room 2.312. The sessions provide an overview of Epidemiological and Statistical Methods in Clinical Investigation. A brochure further describing the sessions is available upon request or at http://www.its.utmb.edu/documents/EpideStatsBrochure.pdf
To register, complete and submit the registration form located on the brochure or contact the Institute for Translational Sciences – Education Office by email CTSA@utmb.edu or phone 772-1484. The course fee of $55 covers registration, letter of completion, Risk Education, GME credit, and refreshments. (Those who have already registered for this year’s course, “Clinical Research: Tools and Techniques” do not need to register again for this module.) To find out more about the Institute for Translational Sciences’ Education Programs, visit “Learning” at: http://www.its.utmb.edu/ .
“Clinical Research: Tools and Techniques”, is a series of 35 weekly sessions offered to faculty, fellows, residents, graduate students and others interested in clinical investigation by the Institute for Translational Sciences – Education Office (Karl E. Anderson, M.D. Course Director). This course will begin Monday, August 13, 2012, 5:15 p.m., Children’s Hospital, Room 2.312. The one-hour sessions provide an overview of ethics, methods, and issues in the conduct of research involving human subjects. Click here for a brochure further describing the sessions. Risk Education, and GME credits are available for selected sessions. The course is also offered to students enrolled in the Graduate School of Biomedical Sciences as PHS 6135.
To register, complete and submit the registration form located on the brochure or on the course website. Those who register may choose to attend any or all sessions and may make up missed sessions the next year. Upon request, participant attendance and self-assessment results may be reported to training program directors.
For more information contact the Institute for Translational Sciences - Education Office at 772-1484. The course fee of $55 covers registration, letter of completion, Risk Education and GME credit, and refreshments.